Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil.
BACKGROUND: The standard treatment for chronic hepatitis C virus (HCV) infection in HIV-infected subjects is the combination of alfapeginterferon (PEG-IFN) plus ribavirin. We designed this study to evaluate the rate of SVR and predictors of SVR in a public health setting in Rio de Janeiro, Brazil. M...
Main Authors: | Halime Silva Barcaui, Gerson Carreiro Tavares, Silvia Beatriz May, Carlos Eduardo Brandão-Mello, Márcia Maria Amendola Pires, Paulo Feijó Barroso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3706550?pdf=render |
Similar Items
-
Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study
by: Giovanni Faria Silva, et al.
Published: (2014-01-01) -
Potential biomarkers to predict sustained virological response of peginterferon plus ribavirin therapy in patients with chronic hepatitis C
by: Yu-Fen Chen, et al.
Published: (2007) -
Increased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.
by: Gabriella Par, et al.
Published: (2013-01-01) -
Prediction of treatment week eight response & sustained virologic response in patients treated with boceprevir plus peginterferon alfa and ribavirin.
by: Alex Thompson, et al.
Published: (2014-01-01) -
Discrepancy between Virological and Biochemical Responses at the End of Interferon or Peginterferon plus Ribavirin Treatment for Chronic Hepatitis C Patients
by: Chun-Hao Chen, et al.
Published: (2008)